This inventor holds 3 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: Liplasome Pharma A/s, Liplasome Pharma Aps. Active years: 2007-2021.
Company Filing History:
Years Active: 2007-2021
Title: Kent Jørgensen: Innovator in Liposomal Drug Delivery
Introduction
Kent Jørgensen is a notable inventor based in Bagsvaerd, Denmark. He has made significant contributions to the field of drug delivery systems, particularly through his innovative work on liposomes. With a total of 3 patents, Jørgensen's inventions focus on enhancing the efficacy of therapeutic agents.
Latest Patents
One of Jørgensen's latest patents is titled "Liposomes for drug delivery and methods for preparation thereof." This invention provides liposomes that are effective for delivering bioactive agents, such as therapeutics, specifically targeting sites with increased secretory phospholipase A2 (sPLA2) activity. This capability is particularly beneficial in cancer therapy, as the liposomes can deliver their payload directly to affected areas. Another significant patent is related to "Lipid-based systems for targeting diagnostic agents." This invention utilizes lipid-based compositions to target diagnostic agents, aiding in the diagnosis of disorders associated with elevated levels of extracellular PLA activity in diseased tissues.
Career Highlights
Kent Jørgensen has worked with Liplasome Pharma A/S and Liplasome Pharma ApS, where he has applied his expertise in liposomal formulations. His work has contributed to advancements in drug delivery technologies, making a positive impact on therapeutic applications.
Collaborations
Throughout his career, Jørgensen has collaborated with notable individuals such as Ole G Mouritsen and Charlotte Vermehren. These collaborations have further enriched his research and development efforts in the field of drug delivery.
Conclusion
Kent Jørgensen's innovative work in liposomal drug delivery systems showcases his commitment to advancing medical technology. His patents reflect a deep understanding of the complexities involved in therapeutic delivery, positioning him as a key figure in this important area of research.